Global Influenza Drugs and Vaccines Market : Opportunities and Forecast (2016-2021) - Azoth Analytics - PowerPoint PPT Presentation

Loading...

PPT – Global Influenza Drugs and Vaccines Market : Opportunities and Forecast (2016-2021) - Azoth Analytics PowerPoint presentation | free to download - id: 8704af-NzlmO



Loading


The Adobe Flash plugin is needed to view this content

Get the plugin now

View by Category
About This Presentation
Title:

Global Influenza Drugs and Vaccines Market : Opportunities and Forecast (2016-2021) - Azoth Analytics

Description:

The report titled “Global Influenza Drugs and Vaccines Market : Opportunities and Forecast (2016-2021). For more mail info@azothanalytics.com – PowerPoint PPT presentation

Number of Views:49

less

Write a Comment
User Comments (0)
Transcript and Presenter's Notes

Title: Global Influenza Drugs and Vaccines Market : Opportunities and Forecast (2016-2021) - Azoth Analytics


1
Global Influenza Drugs and Vaccines Market By
Drugs (Zanamivir, Oseltamivir Phosphate,
Peramivir), By Vaccine (Trivalent, Quadrivalent)
Analysis By Region, By Country Opportunities and
Forecast (2016-2021)
  • By Product Type- Vaccines, Therapeutics
  • By Therapeutics - Relenza (Zanamivir), Tamiflu
    (Oseltamivir Phosphate), Rapivab (Peramivir)
  • By Region-North America, Europe, APAC, ROW
  • By Country US, Canada, UK, France, India, China
  • Policy Regulations
  • Pipeline Analysis

May 2017
1
2
Global Influenza Drugs and Vaccines Market By
Drugs (Zanamivir, Oseltamivir Phosphate,
Peramivir), By Vaccine (Trivalent, Quadrivalent)
Analysis By Region, By Country (2016-2021)
  • Global Coverage
  • Regional Coverage
  • Country Coverage
  • Scope of the Study
  • Segment Coverage
  • Drugs Type
  • Vaccines Type
  • By Drugs - Zanamivir, Oseltamivir Phosphate,
    Peramivir
  • By Vaccines Trivalent, Quadrivalent

Global Coverage
Regional Coverage
Country Coverage
Company Coverage
  • North America
  • Europe
  • Asia Pacific
  • ROW
  • Teva Pharmaceutical Industries Ltd.
  • Emergent Biosolutions
  • Sanofi Pasteur, Inc.
  • GlaxoSmithKline
  • Merck Co., Inc.
  • CSL Limited
  • Astrazeneca
  • Pfizer
  • Serum Institute Of India Pvt. Ltd.
  • Protein Sciences Corporation
  • U.S.
  • Canada
  • U.K.
  • France
  • India
  • China
  • Influenza Market (2011-15)
  • Influenza Market (2016-21)
  • Breakdown-By Product Type
  • Therapeutics (2011-2015)
  • Therapeutics (2016-2021)
  • Vaccines Market (2011-15)
  • Vaccines Market (2016-21)
  • Breakdown-By Therapeutics Type
  • Relenza (zanamivir)
  • Tamiflu (oseltamivir phosphate)
  • Rapivab (peramivir)
  • Influenza Market(2011-15)
  • Influenza Market (2016-21)
  • Influenza Market By Product Type (2011-15)
  • Influenza Market By Product Type (2016-21)
  • Anti-Infective Vaccines Market (2011-15)
  • Anti-Infective Vaccines Market (2016-21)
  • Product Benchmarking
  • Policy and Regulatory Landscape
  • Financial Analysis
  • Sales
  • Business Strategy
  • Market Entry Strategy

2
3
S.No Particulars Particulars Particulars Page No.
1. Introduction Introduction Introduction 14
1.1. Research Methodology Research Methodology 14
1.2. Executive Summary Executive Summary 15
1.3. Strategic Recommendation Strategic Recommendation 16
1.3. Product Overview Product Overview 17
2. Global Influenza Market Overview Global Influenza Market Overview Global Influenza Market Overview 21
2.1. Global Influenza Market Size, By Value, Historic, 2011-2015 Global Influenza Market Size, By Value, Historic, 2011-2015 22
2.2. Global Influenza Market Size, By Value, Forecast, 2016-2021 Global Influenza Market Size, By Value, Forecast, 2016-2021 23
3. Global Influenza Market, Product Analysis Global Influenza Market, Product Analysis Global Influenza Market, Product Analysis 24
3.1. By Product-Actual(2015) By Product-Actual(2015) 25
3.2. By Product-Forecast(2021) By Product-Forecast(2021) 26
3.3. Global Influenza Therapeutics Market , Historic, 2011-2015 Global Influenza Therapeutics Market , Historic, 2011-2015 27
3.4. Global Influenza Therapeutics Market ,Forecast, 2016-2021 Global Influenza Therapeutics Market ,Forecast, 2016-2021 28
3.5. Global Influenza Vaccines Market, Historic, 2011-2015 Global Influenza Vaccines Market, Historic, 2011-2015 29
3.6. Global Influenza Vaccines Market, Forecast, 2016-2021 Global Influenza Vaccines Market, Forecast, 2016-2021 30
3.7. Global Influenza Therapeutics Market, By Drug Type Global Influenza Therapeutics Market, By Drug Type 31
3.7.1. Global Zanamivir Market , Historic, 2011-2015 32
3.7.2. Global Zanamivir Market , Forecast, 2016-2021 33
3.7.3. Global Oseltamivir Phosphate Market , Historic, 2011-2015 35
3.7.4. Global Oseltamivir Phosphate Market , Forecast, 2016-2021 36
3.7.5. Global Peramivir Market , Forecast, 2016-2021 38
3.8. Global Influenza Vaccines Market, By Vaccine Type Global Influenza Vaccines Market, By Vaccine Type 39
3.8.1. Global Trivalent Vaccines Market , Historic, 2011-2015 40
3.8.2. Global Trivalent Vaccines Market , Forecast, 2016-2021 41
3.8.3. Global Quadrivalent Vaccines Market , Historic, 2011-2015 43
3.8.4. Global Quadrivalent Vaccines Market , Forecast, 2016-2021 44
3
4
S.No Particulars Particulars Page No.
4. Global Influenza Vaccines Drugs - Pipeline Analysis Global Influenza Vaccines Drugs - Pipeline Analysis 46
5. Global Influenza Market, By Region Global Influenza Market, By Region 48
5.1. By Region-Actual(2015) 49
5.2. By Region-Actual(2021) 50
6. North America Influenza Market Overview North America Influenza Market Overview 51
6.1. North America Influenza Market Size, By Value, Historic, 2011-2015 52
6.2. North America Influenza Market Size, By Value, Forecast, 2016-2021 53
6.3. North America Influenza Therapeutics Market Size, By Value, Historic, 2011-2015 55
6.4. North America Influenza Therapeutics Market Size, By Value, Forecast , 2016-2021 56
6.5. North America Influenza Vaccines Market Size, By Value, Historic 2011-2015 58
6.6. North America Influenza Vaccines Market Size, By Value, Forecast, 2016-2021 59
6.7. North America Influenza Therapeutics Segment Analysis 60
6.8. North America Influenza Therapeutics Market, By Drug Type, Historic, 2011-2015 61
6.9. North America Influenza Therapeutics Market, By Drug Type, Forecast, 2016-2021 62
6.10. North America Influenza Vaccines Segment Analysis 63
6.11. North America Influenza Vaccines Market, By Vaccine Type, Historic, 2011-2015 64
6.12. North America Influenza Vaccines Market, By Vaccine Type, Forecast, 2016-2021 65
7. United States Influenza Market Overview United States Influenza Market Overview 66
7.1. United States Influenza Market Size, By Value, Historic, 2011-2015 67
7.2. United States Influenza Market Size, By Value, Forecast, 2016-2021 67
7.3. United States Influenza Therapeutics Market Size, By Value, Historic 2011-2015 69
7.4. United States Influenza Therapeutics Market Size, By Value, Forecast, 2016-2021 69
7.5. United States Influenza Vaccines Market Size, By Value, Historic 2011-2015 71
7.6 United States Influenza Vaccines Market Size, By Value, Forecast, 2016-2021 71
7.7. Canada Influenza Market Size, By Value, Historic, 2011-2015 73
7.8. Canada Influenza Market Size, By Value, Forecast, 2016-2021 73
4
5
S.No Particulars Particulars Page No.
7.9. Canada Influenza Therapeutics Market Size, By Value, Historic 2011-2015 75
7.10. Canada Influenza Therapeutics Market Size, By Value, Forecast, 2016-2021 75
7.11. Canada Influenza Vaccines Market Size, By Value, Historic 2011-2015 77
7.12. Canada Influenza Vaccines Market Size, By Value, Forecast, 2016-2021 77
7.13. North America Other Influenza Market Size, By Value, Historic, 2011-2015 79
7.14. North America Other Influenza Market Size, By Value, Forecast, 2016-2021 79
8. Europe Influenza Market Overview Europe Influenza Market Overview 80
8.1. Europe Influenza Market Size, By Value, Historic, 2011-2015 81
8.2. Europe Influenza Market Size, By Value, Forecast, 2016-2021 82
8.3. Europe Influenza Therapeutics Market Size, By Value, Historic, 2011-2015 84
8.4. Europe Influenza Therapeutics Market Size, By Value, Forecast , 2016-2021 85
8.5. Europe Influenza Vaccines Market Size, By Value, Historic 2011-2015 87
8.6. Europe Influenza Vaccines Market Size, By Value, Forecast, 2016-2021 88
8.7. Europe Influenza Therapeutics Segment Analysis 89
8.8. Europe Influenza Therapeutics Market, By Drug Type, Historic, 2011-2015 90
8.9. Europe Influenza Therapeutics Market, By Drug Type, Forecast, 2016-2021 91
8.10. Europe Influenza Vaccines Segment Analysis 92
8.11. Europe Influenza Vaccines Market, By Vaccine Type, Historic, 2011-2015 93
8.12. Europe Influenza Vaccines Market, By Vaccine Type, Forecast, 2016-2021 94
9. United Kingdom Influenza Market Overview United Kingdom Influenza Market Overview 95
9.1. United Kingdom Influenza Market Size, By Value, Historic, 2011-2015 96
9.2. United Kingdom Influenza Market Size, By Value, Forecast, 2016-2021 96
9.3. United Kingdom Influenza Therapeutics Market Size, By Value, Historic 2011-2015 98
9.4. United Kingdom Influenza Therapeutics Market Size, By Value, Forecast, 2016-2021 98
9.5. United Kingdom Influenza Vaccines Market Size, By Value, Historic 2011-2015 100
9.6 United Kingdom Influenza Vaccines Market Size, By Value, Forecast, 2016-2021 100
5
6
S.No Particulars Page No.
10. France Influenza Market Overview France Influenza Market Overview 101
10.1. France Influenza Market Size, By Value, Historic, 2011-2015 102
10.2. France Influenza Market Size, By Value, Forecast, 2016-2021 102
10.3. France Influenza Therapeutics Market Size, By Value, Historic 2011-2015 104
10.4. France Influenza Therapeutics Market Size, By Value, Forecast, 2016-2021 104
10.5. France Influenza Vaccines Market Size, By Value, Historic 2011-2015 106
10.6. France Influenza Vaccines Market Size, By Value, Forecast, 2016-2021 106
10.7. Europe Other Influenza Market Size, By Value, Historic, 2011-2015 108
10.8. Europe Other Influenza Market Size, By Value, Forecast, 2016-2021 108
11. APAC Influenza Market Overview APAC Influenza Market Overview 109
11.1. APAC Influenza Market Size, By Value, Historic, 2011-2015 110
11.2. APAC Influenza Market Size, By Value, Forecast, 2016-2021 111
11.3. APAC Influenza Therapeutics Market Size, By Value, Historic, 2011-2015 113
11.4. APAC Influenza Therapeutics Market Size, By Value, Forecast , 2016-2021 114
11.5. APAC Influenza Vaccines Market Size, By Value, Historic 2011-2015 116
11.6. APAC Influenza Vaccines Market Size, By Value, Forecast, 2016-2021 117
11.7. APAC Influenza Therapeutics Segment Analysis 118
11.8. APAC Influenza Therapeutics Market, By Drug Type, Historic, 2011-2015 119
11.9. APAC Influenza Therapeutics Market, By Drug Type, Forecast, 2016-2021 120
11.10. APAC Influenza Vaccines Segment Analysis 121
11.11. APAC Influenza Vaccines Market, By Vaccine Type, Historic, 2011-2015 122
11.12. APAC Influenza Vaccines Market, By Vaccine Type, Forecast, 2016-2021 123
6
7
S.No Particulars Page No.
12. India Influenza Market Overview India Influenza Market Overview 124
12.1. India Influenza Market Size, By Value, Historic, 2011-2015 125
12.2. India Influenza Market Size, By Value, Forecast, 2016-2021 125
12.3. India Influenza Therapeutics Market Size, By Value, Historic 2011-2015 127
12.4. India Influenza Therapeutics Market Size, By Value, Forecast, 2016-2021 127
12.5. India Influenza Vaccines Market Size, By Value, Historic 2011-2015 128
12.6. India Influenza Vaccines Market Size, By Value, Forecast, 2016-2021 128
13. China Influenza Market Overview China Influenza Market Overview 129
13.1. China Influenza Market Size, By Value, Historic, 2011-2015 130
13.2. China Influenza Market Size, By Value, Forecast, 2016-2021 130
13.3. China Influenza Therapeutics Market Size, By Value, Historic 2011-2015 132
13.4. China Influenza Therapeutics Market Size, By Value, Forecast, 2016-2021 132
13.5. China Influenza Vaccines Market Size, By Value, Historic 2011-2015 134
13.6. China Influenza Vaccines Market Size, By Value, Forecast, 2016-2021 134
13.7. APAC Other Influenza Market Size, By Value, Historic, 2011-2015 136
13.8. APAC Other Influenza Market Size, By Value, Forecast, 2016-2021 136
7
8
S.No Particulars Page No.
14. ROW Influenza Market Overview ROW Influenza Market Overview 137
14.1. ROW Influenza Market Size, By Value, Historic, 2011-2015 138
14.2. ROW Influenza Market Size, By Value, Historic , 2016-2021 139
15. Market Dynamics Market Dynamics 140
15.1. Drivers 140
15.2. Challenges 145
15.3. Trends 148
16. Company Profiles Company Profiles 153
16.1. GlaxoSmithKline 154
16.2. Sanofi Pasteur, Inc. 155
16.3. CSL Limited 156
16.4. Astrazeneca 157
16.5. Protein Sciences Corporation 158
16.6. Serum Institute Of India Pvt. Ltd. 159
16.7. Emergent Biosolutions 160
16.8. Gilead Sciences 161
16.9. BioCryst Pharmaceuticals.Inc. 162
16.10. Alvogen 163
17. About Us About Us 164
8
9
List of Figures
Figure No. Figure Title Page No.
Figure 1 Global Influenza Market Size, By Value, 2011-2015 (USD Billion) 22
Figure 2 Global Influenza Market Size, By Value, 2016E-2021F (USD Billion) 23
Figure 3 Global Influenza Market Size and Share, By Product, 2015 25
Figure 4 Key Drivers 25
Figure 5 Global Influenza Market Size and Share, By Product, 2021F 26
Figure 6 Key Drivers 26
Figure 7 Global Influenza Therapeutics Market Size, By Value, 2011-2015 (USD Billion) 27
Figure 8 Global Influenza Therapeutics Market Size, By Value, 2016E-2021F (USD Billion) 28
Figure 9 Global Influenza Vaccines Market Size, By Value, 2011-2015 (USD Billion) 29
Figure 10 Global Influenza Vaccines Market Size, By Value, 2016E-2021F (USD Billion) 30
Figure 11 Global Zanamivir Market Size, By Value, 2011-2015 (USD Billion) 32
Figure 12 Global Zanamivir Market Size, By Value, 2016E-2021F (USD Billion) 33
Figure 13 Global Oseltamivir Phosphate Market Size, By Value, 2011-2015 (USD Billion) 35
Figure 14 Global Oseltamivir Phosphate Market Size, By Value, 2016E-2021F (USD Billion) 36
Figure 15 Global Peramivir Market Size, By Value, 2016E-2021F (USD Billion) 38
Figure 16 Global Trivalent Vaccines Market Size, By Value, 2011-2015 (USD Billion) 40
Figure 17 Global Trivalent Vaccines Market Size, By Value, 2016E-2021F (USD Billion) 41
Figure 18 Global Quadrivalent Vaccines Market Size, By Value, 2011-2015 (USD Billion) 43
Figure 19 Global Quadrivalent Vaccines Market Size, By Value, 2016E-2021F (USD Billion 44
9
10
List of Figures
Figure No. Figure Title Page No.
Figure 20 Global Influenza Market Size and Share, By Region, 2015 49
Figure 21 Key Drivers 49
Figure 22 Global Influenza Market Size and Share, By Region, 2021F 50
Figure 23 Key Drivers 50
Figure 24 North America Influenza Market Size, By Value, 2011-2015 (USD Billion) 52
Figure 25 North America Influenza Market Size, By Value, 2016E-2021F (USD Billion) 53
Figure 26 North America Influenza Therapeutics Market Size, By Value, 2011-2015 (USD Billion) 55
Figure 27 North America Influenza Therapeutics Market Size, By Value, 2016E-2021F (USD Billion) 56
Figure 28 North America Influenza Vaccines Market Size, By Value, 2011-2015 (USD Billion) 58
Figure 29 North America Influenza Vaccines Market Size, By Value, 2016E-2021F (USD Billion) 59
Figure 30 North America Influenza Therapeutics Market By Product, By Value, 2011-2015 (USD Billion) 61
Figure 31 North America Influenza Therapeutics Market By Therapeutics Type, By Value, 2016E-2021F (USD Billion) 62
Figure 32 North America Influenza Vaccines Market By Product Type, By Value, 2011-2015 (USD Billion) 64
Figure 33 North America Influenza Vaccines Market By Product, By Value, 2016E-2021F (USD Billion) 65
Figure 34 US Influenza Market Size, By Value, 2011-2021(USD Billion) 67
Figure 35 US Influenza Therapeutics Market Size, By Value, 2011-2021(USD Billion) 69
Figure 36 US Influenza Vaccines Market Size, By Value, 2011-2021(USD Billion) 71
10
11
List of Figures
Figure No. Figure Title Page No.
Figure 37 Canada Influenza Market Size, By Value, 2011-2021(USD Billion) 73
Figure 38 Canada Influenza Therapeutics Market Size, By Value, 2011-2021(USD Billion) 75
Figure 39 Canada Influenza Vaccines Market Size, By Value, 2011-2021(USD Billion) 77
Figure 40 North America Others Influenza Market Size, By Value, 2011-2021 (USD Billion) 79
Figure 41 Europe Influenza Market Size, By Value, 2011-2015 (USD Billion) 81
Figure 42 Europe Influenza Market Size, By Value, 2016E-2021F (USD Billion) 82
Figure 43 Europe Influenza Therapeutics Market Size, By Value, 2011-2015 (USD Billion) 84
Figure 44 Europe Influenza Therapeutics Market Size, By Value, 2016E-2021F (USD Billion) 85
Figure 45 Europe Influenza Vaccines Market Size, By Value, 2011-2015 (USD Billion) 87
Figure 46 Europe Influenza Vaccines Market Size, By Value, 2016E-2021F (USD Billion) 88
Figure 47 Europe Influenza Therapeutics Market By Product, By Value, 2011-2015 (USD Billion) 90
Figure 48 Europe Influenza Therapeutics Market By Therapeutics Type, By Value, 2016E-2021F (USD Billion) 91
Figure 49 Europe Influenza Vaccines Market By Product Type, By Value, 2011-2015 (USD Billion) 93
Figure 50 Europe Influenza Vaccines Market By Product, By Value, 2016E-2021F (USD Billion) 94
Figure 51 UK Influenza Market Size, By Value, 2011-2021(USD Billion) 96
Figure 52 UK Influenza Therapeutics Market Size, By Value, 2011-2021(USD Billion) 98
Figure 53 UK Influenza Vaccines Market Size, By Value, 2011-2021(USD Billion) 100
11
12
List of Figures
Figure No. Figure Title Page No.
Figure 54 France Influenza Market Size, By Value, 2011-2021(USD Billion) 102
Figure 55 France Influenza Therapeutics Market Size, By Value, 2011-2021(USD Billion) 104
Figure 56 France Influenza Vaccines Market Size, By Value, 2011-2021(USD Billion) 106
Figure 57 Europe Others Influenza Market Size, By Value, 2011-2021 (USD Billion) 108
Figure 58 APAC Influenza Market Size, By Value, 2011-2015 (USD Billion) 110
Figure 59 APAC Influenza Market Size, By Value, 2016E-2021F (USD Billion) 111
Figure 60 APAC Influenza Therapeutics Market Size, By Value, 2011-2015 (USD Billion 113
Figure 61 APAC Influenza Therapeutics Market Size, By Value, 2016E-2021F (USD Billion) 114
Figure 62 APAC Influenza Vaccines Market Size, By Value, 2011-2015 (USD Billion) 116
Figure 63 APAC Influenza Vaccines Market Size, By Value, 2016E-2021F (USD Billion) 117
Figure 64 APAC Influenza Therapeutics Market By Product, By Value, 2011-2015 (USD Billion) 119
Figure 65 APAC Influenza Therapeutics Market By Therapeutics Type, By Value, 2016E-2021F (USD Billion) 120
Figure 66 APAC Influenza Vaccines Market By Product Type, By Value, 2011-2015 (USD Billion) 122
Figure 67 APAC Influenza Vaccines Market By Product, By Value, 2016E-2021F (USD Billion) 123
Figure 68 India Influenza Market Size, By Value, 2011-2021(USD Billion) 125
Figure 69 India Influenza Therapeutics Market Size, By Value, 2011-2021(USD Billion) 127
Figure 70 India Influenza Vaccines Market Size, By Value, 2011-2021(USD Billion) 128
12
13
List of Figures
Figure No. Figure Title Page No.
Figure 71 China Influenza Market Size, By Value, 2011-2021(USD Billion) 130
Figure 72 China Influenza Therapeutics Market Size, By Value, 2011-2021(USD Billion) 132
Figure 73 China Influenza Vaccines Market Size, By Value, 2011-2021(USD Billion) 134
Figure 74 APAC Others Influenza Market Size, By Value, 2011-2021 (USD Billion) 136
Figure 75 ROW Influenza Market Size, By Value, 2011-2015 (USD Million) 138
Figure 76 ROW Influenza Market Size, By Value, 2016E-2021F (USD Million) 139
Table A Influenza Pipe analysis 46
Table B Influenza Pipe analysis 47
13
14
Global Influenza Market- Product Analysis
Rising number of cases around the globe along
with rising awareness regarding the drug have
been propelling the market for influenza
vaccination.
Figure Global Influenza Market Size and Share,
By Product, 2015
Figure Key Drivers
Source Azoth Analytics
14
15
Global Influenza Vaccines Market
Rising affordability of the population along with
increasing awareness among them and development
of a global vaccine is anticipated to drive the
market in the forecast period.
Source Azoth Analytics Estimates
  • xxxx
  • xxxxx
  • xxxxx
  • Xxxx
  • Xxxx
  • xxxx
  • .

15
16
North America Influenza Therapeutics Market
CAGR 2016E-2021F Zanamivir x , Oseltamivir
Phosphate x, Peramivir x
Source Azoth Analytics Estimates
  • Xx
  • Xx
  • Xx
  • Xx
  • xx

16
17
France Influenza Market Overview
France Influenza Market is witnessing growth due
to high penetration of vaccines and drugs in this
country as compared to other less developed
countries.
CAGR xxx
Source Azoth Analytics Estimates
  • xxxx
  • xxxxx
  • xxxx
  • xxxx
  • xxxxx
  • .

17
18
APAC Others Influenza Market Overview
The changed perception of the general population
and continuous improvements in the formulations
of the vaccines and drugs is leading to the
growth of this market.
CAGR xxx
Source Azoth Analytics Estimates
  • xxxx
  • xxxx
  • xxxx
  • xxxxx
  • xxxxx
  • xxxxx
  • .

18
19
Research Methodology
19
20
Global Influenza Drugs and Vaccines Market By
Drugs (Zanamivir, Oseltamivir Phosphate,
Peramivir), By Vaccine (Trivalent, Quadrivalent)
- Analysis By Region, By Country Opportunities
and Forecast (2016-2021)- - By Region (North
America, Europe, APAC, ROW), By Country (U.S.,
Canada, U.K., Germany, France, China, India,
Japan) Publish Date May 2017 No. of
Pages164 Price USD 2000 (Single User License)
Price USD 3000 (Multi- User License) To View
Sample Report or Purchase Report Click Here
Contact Us
ASIA PACIFIC

EUROPE


Mail info_at_azothanalytics.com

Mail shipra_at_azothanalytics.com
Phone 91 120 429 8235

Phone 44 - 744 - 8107625
NORTH AMERICA

Call for Assistance


Mail tanvi_at_azothanalytics.com

Phone 91 9873 4262
88Phone 1 - 321 - 444 9707

Sales Enquiry  


Phone 91 120
429 8235
www.azothanalytics.com
20
About PowerShow.com